🇺🇸 United States · Hippocratic AI — Conversational Health AI for Patients

Status: 🟩 COMPLETE 🟦 LIVING Section: 10 — AI and LLMs


Vendor	Hippocratic AI
Country/origin	🇺🇸 United States (Palo Alto, California)
Recommended for AUS?	✅ Yes for enterprise/health system deployments — US company; HIPAA compliant; designed with clinical safety
Privacy summary	HIPAA compliant; enterprise healthcare data handling; SOC 2 Type II; PHI (Protected Health Information) protections; not available to general consumers directly
Free tier	No — enterprise healthcare organisations only
Paid tiers	Enterprise healthcare pricing (not public; per-conversation or contract)
First released	Founded 2023; product launched to healthcare partners 2023–2024
Last reviewed	June 2026
Official site	https://hippocratic.ai

What it is

Hippocratic AI is an AI company building conversational AI agents specifically for healthcare — not general-purpose AI applied to health, but AI that is designed, trained, evaluated, and deployed with clinical safety as the primary concern.

The name comes from the Hippocratic oath (“first, do no harm”) — signalling that the product’s core design principle is safety above capability.

What Hippocratic AI does:

Provides AI-powered patient communication agents that can have spoken or text conversations with patients about:
- Chronic disease management (diabetes, hypertension, heart disease)
- Pre- and post-procedure preparation and follow-up
- Medication reminders and adherence
- Care plan navigation and health literacy
- Benefits navigation and appointment scheduling
- Social determinants of health (housing, food security, transportation)

Critically: Hippocratic AI is positioned as a clinical support and patient engagement tool, not a diagnostic AI. It doesn’t make diagnoses; it helps patients understand their care plans, remember medications, prepare for procedures, and communicate with their care teams.

Why this matters (the nurse shortage context)

The fundamental problem Hippocratic AI addresses: there are not enough nurses, health coaches, and care navigators to provide the kind of personalised ongoing support that patients with chronic conditions need.

US statistics: 1.2 million nurse vacancies projected by 2030
Australia: Similar workforce shortages across rural and remote areas, aged care, and specialist nursing
Chronic disease management requires regular patient touch-points that the healthcare system can’t staff adequately

Hippocratic AI’s agents can have thousands of patient conversations simultaneously — things like weekly check-ins with diabetic patients, post-discharge follow-up calls, medication adherence reminders — freeing human nurses and physicians for tasks requiring clinical judgment.

The clinical safety design approach

Hippocratic AI makes specific choices that distinguish it from general AI applied to health:

Scope limitations: The AI is explicitly trained to stay within its competency. When a patient asks a question outside its scope (“should I change my dose?”) it says so clearly and directs to a clinician.
Benchmarked against licensed professionals: Hippocratic has published benchmarks showing its AI against registered nurses and health coaches on tasks like patient education — not for diagnostics, but for communication quality.
Clinical oversight: Healthcare organisations deploying Hippocratic AI configure scope, escalation paths, and supervise AI interactions. A human clinician reviews flagged conversations.
Safe messaging guidelines: Built-in adherence to guidelines for sensitive topics (suicidality, eating disorders, substance use) — the AI doesn’t improvise in clinical danger zones.
Dual safeguards: Both input and output are filtered for clinical safety.

Australian context

Australia faces significant healthcare workforce shortages, particularly:

Rural and remote health access gaps
Aged care staffing shortages (especially post-Royal Commission)
Chronic disease burden in Indigenous communities
General practice access issues

Hippocratic AI’s model is relevant for Australian health systems, but:

Currently focused on US health system deployment (insurance-based; Medicare/Medicaid workflows)
Australian deployment would require adaptation to Medicare Australia, My Health Record, and PBS (Pharmaceutical Benefits Scheme) workflows
AHPRA (Australian Health Practitioner Regulation Agency) and TGA (Therapeutic Goods Administration) have regulatory jurisdiction over AI in healthcare in Australia
As of mid-2026, no confirmed Australian health system deployments

How to access (Australian healthcare organisations)

Hippocratic AI is not consumer-accessible. Access is through:

Contact hippocratic.ai for enterprise partnership discussions
Applicable for: hospital systems, health insurers, aged care providers, PHNs (Primary Health Networks), health departments
Pilot programs are the typical entry point

Comparison to other health AI

Tool	Country	Focus	Consumer access?
Hippocratic AI	🇺🇸	Patient engagement; chronic disease	No — enterprise only
OpenEvidence	🇺🇸	Clinical decision support for clinicians	Clinicians only
K Health	🇮🇱🇺🇸	Primary care AI for patients	Consumer app (US)
Ada Health	🇩🇪	Symptom checker; patient triage	Consumer app (global)
Infermedica	🇵🇱	Symptom checking; triage API	Enterprise API
ChatGPT/Claude for health	🇺🇸	General purpose; not healthcare-specific	Consumer (not recommended for clinical use)

Hippocratic AI’s niche: the safest and most clinically appropriate for patient-facing chronic disease conversations in a healthcare enterprise context.

Privacy / data handling

HIPAA compliant — the US law governing health data privacy (Protected Health Information)
SOC 2 Type II certified
Healthcare enterprise data handling standards
Patient conversations are not used to train general AI models
Enterprise contracts include BAAs (Business Associate Agreements) required under HIPAA

Australian note: In Australia, health information is “sensitive information” under the Privacy Act 1988 and the Australian Privacy Principles (APPs) impose heightened obligations. The Privacy Act and Health Records Act (various states) would apply to any Australian deployment. The TGA would evaluate whether the AI constitutes a medical device.

Gotchas

Not for diagnosis or treatment decisions. Hippocratic AI is explicitly not designed for clinical decision-making — only patient engagement and support. Misrepresenting its capabilities to patients would be both unethical and regulatory-violating.
Not consumer-accessible. If you’re an individual wanting health AI support, this isn’t available to you directly. Ada Health, K Health, or general AI assistants (with appropriate caveats) are consumer-facing options.
US health system integration. The product is built around US insurance workflows. Australian deployment requires significant customisation.
AI in healthcare is highly regulated. Any Australian health organisation considering AI like Hippocratic needs specialist health law and TGA regulatory advice.
The evidence base is still developing. Clinical validation studies for AI in patient engagement are emerging but not as extensive as traditional medical evidence. Monitor published outcomes.

Sources

Hippocratic AI official site: hippocratic.ai
Hippocratic AI clinical benchmarking publications (2023–2024)
STAT News, Healthcare IT News coverage of Hippocratic AI (2023–2024)
TGA (Therapeutic Goods Administration) — AI as a medical device guidance (2023–2024)
AHPRA guidance on AI in healthcare practice (2024)
Privacy Act 1988 (Australia) — sensitive information and health records
HIPAA (US) — Health Insurance Portability and Accountability Act

Tech & AI, Explained

Explorer

hippocratic-ai